Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06690983 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tau PET/CT in Various Tau-Related Disease Patients

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 2 to 3v4
  2. Start date: Nov 1, 2024 to Aug 1, 2018
    • Site contacts updated at 1 of 2 sites
    v3
  3. Study sites: 1 to 2
    • Primary completion date: Nov 2027 to Nov 1, 2027
    • Study completion date: Dec 2027 to Dec 1, 2027
    • Start date changed from estimate of Nov 2024 to Nov 1, 2024
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the potential usefulness of 18F-S16/T807 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.
Trial Details
NCT Number NCT06690983
Lead Sponsor Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital
Conditions
(from sponsor)		 Tauopathies, Neurodegenerative Diseases, Neurodegeneration
Related terms Nerve Degeneration, Neurodegenerative Diseases, Pick Disease of the Brain, Tauopathies
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov